KYOTO, Japan--(BUSINESS WIRE)--Megakaryon Corporation (hereinafter, Megakaryon) today announces its clinical trial of allogenic human iPSC-derived HLA homozygous platelets (Development Code: MEG-002) ...
Determining the specificity of HLA antibodies is arguably one of the most important contributions by the HLA laboratory today. For patients that have low-to-moderate levels of antibody, using a ...
Both genetic factors and environmental influences, including infection with Epstein–Barr virus, contribute to multiple sclerosis susceptibility. The association between susceptibility to multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results